Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

Parkinson’s disease drug hunters think outside the α-synuclein box

7 December 2022

Nature Biotechnology

Read more
(behind paywall)

https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/nature_biotechnology-logo.jpg 819 1238 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2022-12-07 08:00:392026-09-10 10:25:57Parkinson’s disease drug hunters think outside the α-synuclein box

© NRG Therapeutics

Terms & Conditions
Privacy Policy

NRG raises Series A funds for Parkinson’s and ALS therapy development

Case Study: R&D grant funding